Literature DB >> 25854680

How to interpret multidimensional quality of life questionnaires for patients with schizophrenia?

Pierre Michel1,2, Pascal Auquier1, Karine Baumstarck1, Anderson Loundou1, Badih Ghattas2, Christophe Lançon1, Laurent Boyer3.   

Abstract

PURPOSE: The classification of patients into distinct categories of quality of life (QoL) levels may be useful for clinicians to interpret QoL scores from multidimensional questionnaires. The aim of this study had been to define clusters of QoL levels from a specific multidimensional questionnaire (SQoL18) for patients with schizophrenia by using a new method of interpretable clustering and to test its validity regarding socio-demographic, clinical, and QoL information.
METHODS: In this multicentre cross-sectional study, patients with schizophrenia have been classified using a hierarchical top-down method called clustering using unsupervised binary trees (CUBT). A three-group structure has been employed to define QoL levels as "high", "moderate", or "low". Socio-demographic, clinical, and QoL data have been compared between the three clusters to ensure their clinical relevance.
RESULTS: A total of 514 patients have been analysed: 78 are classified as "low", 265 as "moderate", and 171 as "high". The clustering shows satisfactory statistical properties, including reproducibility (using bootstrap analysis) and discriminancy (using factor analysis). The three clusters consistently differentiate patients. As expected, individuals in the "high" QoL level cluster report the lowest scores on the Positive and Negative Syndrome Scale (p = 0.01) and the Calgary Depression Scale (p < 0.01), and the highest scores on the Global Assessment of Functioning (p < 0.03), the SF36 (p < 0.01), the EuroQol (p < 0.01), and the Quality of Life Inventory (p < 0.01).
CONCLUSION: Given the ease with which this method can be applied, classification using CUBT may be useful for facilitating the interpretation of QoL scores in clinical practice.

Entities:  

Keywords:  Clustering; Quality of life; SF36; SQoL18; Schizophrenia; Unsupervised classification

Mesh:

Year:  2015        PMID: 25854680     DOI: 10.1007/s11136-015-0982-y

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  33 in total

1.  Is the use of QOL data really any different than other medical testing?

Authors:  Michele Y Halyard; Marlene H Frost; Amylou Dueck; Jeff A Sloan
Journal:  Curr Probl Cancer       Date:  2006 Nov-Dec       Impact factor: 3.187

Review 2.  Measuring quality of life in patients with schizophrenia:an overview.

Authors:  Laurent Boyer; Karine Baumstarck; Mohamed Boucekine; Julien Blanc; Christophe Lançon; Pascal Auquier
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2013-06       Impact factor: 2.217

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

4.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

5.  Defining Quality of Life Levels to Enhance Clinical Interpretation in Multiple Sclerosis: Application of a Novel Clustering Method.

Authors:  Pierre Michel; Karine Baumstarck; Laurent Boyer; Oscar Fernandez; Peter Flachenecker; Jean Pelletier; Anderson Loundou; Badih Ghattas; Pascal Auquier
Journal:  Med Care       Date:  2017-01       Impact factor: 2.983

6.  Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: the S-QoL.

Authors:  P Auquier; M C Simeoni; C Sapin; G Reine; V Aghababian; J Cramer; C Lançon
Journal:  Schizophr Res       Date:  2003-09-01       Impact factor: 4.939

Review 7.  Improving patient outcomes through the routine use of patient-reported data in cancer clinics: future directions.

Authors:  T Luckett; P N Butow; M T King
Journal:  Psychooncology       Date:  2009-11       Impact factor: 3.894

8.  Improved quality of life over one year is associated with improved adherence in patients with schizophrenia.

Authors:  K P Hayhurst; R J Drake; J A Massie; G Dunn; T R E Barnes; P B Jones; S W Lewis
Journal:  Eur Psychiatry       Date:  2013-06-12       Impact factor: 5.361

9.  Evaluating the impact of a quality of life assessment with feedback to clinicians in patients with schizophrenia: randomised controlled trial.

Authors:  Laurent Boyer; Christophe Lançon; Karine Baumstarck; Nathalie Parola; Julie Berbis; Pascal Auquier
Journal:  Br J Psychiatry       Date:  2013-05-09       Impact factor: 9.319

10.  Empirically driven definitions of "good," "moderate," and "poor" levels of functioning in the treatment of schizophrenia.

Authors:  Haya Ascher-Svanum; Diego Novick; Josep Maria Haro; Jaume Aguado; Zhanglin Cui
Journal:  Qual Life Res       Date:  2012-12-14       Impact factor: 4.147

View more
  1 in total

1.  Subjectively different but objectively the same? Three profiles of QoL in people with severe mental health problems.

Authors:  David C Buitenweg; Ilja L Bongers; Dike van de Mheen; Hans A M van Oers; Chijs van Nieuwenhuizen
Journal:  Qual Life Res       Date:  2018-08-13       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.